Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 112 entries
Sorted by: Best Match Show Resources per page
Ventilator-associated conditions versus ventilator-associated pneumonia: different by design.

Current infectious disease reports

Klompas M.
PMID: 25129117
Curr Infect Dis Rep. 2014 Oct;16(10):430. doi: 10.1007/s11908-014-0430-0.

The Centers for Disease Control and Prevention (CDC) released a new surveillance concept called ventilator-associated conditions (VACs) in early 2013. VAC was created to overcome some of the limitations of traditional ventilator-associated pneumonia (VAP) definitions, including their complexity, subjectivity,...

Cite
Klompas M. Ventilator-associated conditions versus ventilator-associated pneumonia: different by design. Curr Infect Dis Rep. 2014;16(10):430doi: 10.1007/s11908-014-0430-0.
Klompas, M. (2014). Ventilator-associated conditions versus ventilator-associated pneumonia: different by design. Current infectious disease reports, 16(10), 430. https://doi.org/10.1007/s11908-014-0430-0
Klompas, Michael. "Ventilator-associated conditions versus ventilator-associated pneumonia: different by design." Current infectious disease reports vol. 16,10 (2014): 430. doi: https://doi.org/10.1007/s11908-014-0430-0
Klompas M. Ventilator-associated conditions versus ventilator-associated pneumonia: different by design. Curr Infect Dis Rep. 2014 Oct;16(10):430. doi: 10.1007/s11908-014-0430-0. PMID: 25129117.
Copy Download .nbib Format: NLM
Staphylococcus intermedius infections: case report and literature review.

Infectious disease reports

Wang N, Neilan AM, Klompas M.
PMID: 24470954
Infect Dis Rep. 2013 Jan 22;5(1):e3. doi: 10.4081/idr.2013.e3. eCollection 2013 Jan 22.

Staphylococcus intermedius is part of the normal skin and oral flora of dogs. Case reports of human infections are rare, but the true incidence is unknown because the pathogen is frequently misidentified as Staphylococcus aureus. Reported cases range from...

Cite
Wang N, Neilan AM, Klompas M. Staphylococcus intermedius infections: case report and literature review. Infect Dis Rep. 2013;5(1):e3doi: 10.4081/idr.2013.e3.
Wang, N., Neilan, A. M., & Klompas, M. (2013). Staphylococcus intermedius infections: case report and literature review. Infectious disease reports, 5(1), e3. https://doi.org/10.4081/idr.2013.e3
Wang, Nancy, et al. "Staphylococcus intermedius infections: case report and literature review." Infectious disease reports vol. 5,1 (2013): e3. doi: https://doi.org/10.4081/idr.2013.e3
Wang N, Neilan AM, Klompas M. Staphylococcus intermedius infections: case report and literature review. Infect Dis Rep. 2013 Jan 22;5(1):e3. doi: 10.4081/idr.2013.e3. eCollection 2013 Jan 22. PMID: 24470954; PMCID: PMC3892614.
Copy Download .nbib Format: NLM
Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019.

Current infectious disease reports

Willis SJ, Cocoros NM, Randall LM, Ochoa AM, Haney G, Hsu KK, DeMaria A, Klompas M.
PMID: 31451945
Curr Infect Dis Rep. 2019 Aug 26;21(10):32. doi: 10.1007/s11908-019-0694-5.

PURPOSE OF REVIEW: Electronic health records (EHRs) are an excellent source of data for disease symptoms, laboratory results, and medical treatments. Thus, EHR data may improve the completeness of notifiable disease case reporting and enable longitudinal collection of disease...

Cite
Willis SJ, Cocoros NM, Randall LM, et al. Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019. Curr Infect Dis Rep. 2019;21(10):32doi: 10.1007/s11908-019-0694-5.
Willis, S. J., Cocoros, N. M., Randall, L. M., Ochoa, A. M., Haney, G., Hsu, K. K., DeMaria, A., & Klompas, M. (2019). Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019. Current infectious disease reports, 21(10), 32. https://doi.org/10.1007/s11908-019-0694-5
Willis, Sarah J, et al. "Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019." Current infectious disease reports vol. 21,10 (2019): 32. doi: https://doi.org/10.1007/s11908-019-0694-5
Willis SJ, Cocoros NM, Randall LM, Ochoa AM, Haney G, Hsu KK, DeMaria A, Klompas M. Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019. Curr Infect Dis Rep. 2019 Aug 26;21(10):32. doi: 10.1007/s11908-019-0694-5. PMID: 31451945.
Copy Download .nbib Format: NLM
Institutional impediments to conservation of freshwater dependent ecosystems.

The Science of the total environment

Spring DA, Croft L, Bond NR, Cunningham SC, Mac Nally R, Kompas T.
PMID: 29190563
Sci Total Environ. 2018 Apr 15;621:407-416. doi: 10.1016/j.scitotenv.2017.11.232. Epub 2017 Nov 28.

When freshwater resources become scarce there is a trade-off between human resource demands and environmental sustainability. The cost of conserving freshwater ecosystems can potentially be reduced by implementing institutional reforms that endow environmental water managers with a permanent water...

Cite
Spring DA, Croft L, Bond NR, et al. Institutional impediments to conservation of freshwater dependent ecosystems. Sci Total Environ. 2017;621:407-416doi: 10.1016/j.scitotenv.2017.11.232.
Spring, D. A., Croft, L., Bond, N. R., Cunningham, S. C., Mac Nally, R., & Kompas, T. (2018). Institutional impediments to conservation of freshwater dependent ecosystems. The Science of the total environment, 621407-416. https://doi.org/10.1016/j.scitotenv.2017.11.232
Spring, Daniel A, et al. "Institutional impediments to conservation of freshwater dependent ecosystems." The Science of the total environment vol. 621 (2018): 407-416. doi: https://doi.org/10.1016/j.scitotenv.2017.11.232
Spring DA, Croft L, Bond NR, Cunningham SC, Mac Nally R, Kompas T. Institutional impediments to conservation of freshwater dependent ecosystems. Sci Total Environ. 2018 Apr 15;621:407-416. doi: 10.1016/j.scitotenv.2017.11.232. Epub 2017 Nov 28. PMID: 29190563.
Copy Download .nbib Format: NLM
Impact of Risk Adjustment Using Clinical vs Administrative Data on Hospital Sepsis Mortality Comparisons.

Open forum infectious diseases

Rhee C, Li Z, Wang R, Song Y, Kadri SS, Septimus EJ, Chen HC, Fram D, Jin R, Poland R, Sands K, Klompas M.
PMID: 32617377
Open Forum Infect Dis. 2020 Jun 25;7(6):ofaa213. doi: 10.1093/ofid/ofaa213. eCollection 2020 Jun.

BACKGROUND: A reliable risk-adjusted sepsis outcome measure could complement current national process metrics by identifying outlier hospitals and catalyzing additional improvements in care. However, it is unclear whether integrating clinical data into risk adjustment models identifies similar high- and...

Cite
Rhee C, Li Z, Wang R, et al. Impact of Risk Adjustment Using Clinical vs Administrative Data on Hospital Sepsis Mortality Comparisons. Open Forum Infect Dis. 2020;7(6):ofaa213doi: 10.1093/ofid/ofaa213.
Rhee, C., Li, Z., Wang, R., Song, Y., Kadri, S. S., Septimus, E. J., Chen, H. C., Fram, D., Jin, R., Poland, R., Sands, K., & Klompas, M. (2020). Impact of Risk Adjustment Using Clinical vs Administrative Data on Hospital Sepsis Mortality Comparisons. Open forum infectious diseases, 7(6), ofaa213. https://doi.org/10.1093/ofid/ofaa213
Rhee, Chanu, et al. "Impact of Risk Adjustment Using Clinical vs Administrative Data on Hospital Sepsis Mortality Comparisons." Open forum infectious diseases vol. 7,6 (2020): ofaa213. doi: https://doi.org/10.1093/ofid/ofaa213
Rhee C, Li Z, Wang R, Song Y, Kadri SS, Septimus EJ, Chen HC, Fram D, Jin R, Poland R, Sands K, Klompas M. Impact of Risk Adjustment Using Clinical vs Administrative Data on Hospital Sepsis Mortality Comparisons. Open Forum Infect Dis. 2020 Jun 25;7(6):ofaa213. doi: 10.1093/ofid/ofaa213. eCollection 2020 Jun. PMID: 32617377; PMCID: PMC7320830.
Copy Download .nbib Format: NLM
Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data.

Critical care explorations

Rhee C, Wang R, Song Y, Zhang Z, Kadri SS, Septimus EJ, Fram D, Jin R, Poland RE, Hickok J, Sands K, Klompas M.
PMID: 32166230
Crit Care Explor. 2019 Oct 14;1(10):e0049. doi: 10.1097/CCE.0000000000000049. eCollection 2019 Oct.

Variability in hospital-level sepsis mortality rates may be due to differences in case mix, quality of care, or diagnosis and coding practices. Centers for Disease Control and Prevention's Adult Sepsis Event definition could facilitate objective comparisons of sepsis mortality...

Cite
Rhee C, Wang R, Song Y, et al. Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Crit Care Explor. 2019;1(10):e0049doi: 10.1097/CCE.0000000000000049.
Rhee, C., Wang, R., Song, Y., Zhang, Z., Kadri, S. S., Septimus, E. J., Fram, D., Jin, R., Poland, R. E., Hickok, J., Sands, K., & Klompas, M. (2019). Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Critical care explorations, 1(10), e0049. https://doi.org/10.1097/CCE.0000000000000049
Rhee, Chanu, et al. "Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data." Critical care explorations vol. 1,10 (2019): e0049. doi: https://doi.org/10.1097/CCE.0000000000000049
Rhee C, Wang R, Song Y, Zhang Z, Kadri SS, Septimus EJ, Fram D, Jin R, Poland RE, Hickok J, Sands K, Klompas M. Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Crit Care Explor. 2019 Oct 14;1(10):e0049. doi: 10.1097/CCE.0000000000000049. eCollection 2019 Oct. PMID: 32166230; PMCID: PMC7063887.
Copy Download .nbib Format: NLM
Association Between Residual Inhibition and Neural Activity in Patients with Tinnitus: Protocol for a Controlled Within- and Between-Subject Comparison Study.

JMIR research protocols

Hu S, Anschuetz L, Huth ME, Sznitman R, Blaser D, Kompis M, Hall DA, Caversaccio M, Wimmer W.
PMID: 30626571
JMIR Res Protoc. 2019 Jan 09;8(1):e12270. doi: 10.2196/12270.

BACKGROUND: Electroencephalography (EEG) studies indicate possible associations between tinnitus and changes in the neural activity. However, inconsistent results require further investigation to better understand such heterogeneity and inform the interpretation of previous findings.OBJECTIVE: This study aims to investigate the...

Cite
Hu S, Anschuetz L, Huth ME, et al. Association Between Residual Inhibition and Neural Activity in Patients with Tinnitus: Protocol for a Controlled Within- and Between-Subject Comparison Study. JMIR Res Protoc. 2019;8(1):e12270doi: 10.2196/12270.
Hu, S., Anschuetz, L., Huth, M. E., Sznitman, R., Blaser, D., Kompis, M., Hall, D. A., Caversaccio, M., & Wimmer, W. (2019). Association Between Residual Inhibition and Neural Activity in Patients with Tinnitus: Protocol for a Controlled Within- and Between-Subject Comparison Study. JMIR research protocols, 8(1), e12270. https://doi.org/10.2196/12270
Hu, Suyi, et al. "Association Between Residual Inhibition and Neural Activity in Patients with Tinnitus: Protocol for a Controlled Within- and Between-Subject Comparison Study." JMIR research protocols vol. 8,1 (2019): e12270. doi: https://doi.org/10.2196/12270
Hu S, Anschuetz L, Huth ME, Sznitman R, Blaser D, Kompis M, Hall DA, Caversaccio M, Wimmer W. Association Between Residual Inhibition and Neural Activity in Patients with Tinnitus: Protocol for a Controlled Within- and Between-Subject Comparison Study. JMIR Res Protoc. 2019 Jan 09;8(1):e12270. doi: 10.2196/12270. PMID: 30626571; PMCID: PMC6329433.
Copy Download .nbib Format: NLM
The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Karan A, Klompas M, Tucker R, Baker M, Vaidya V, Rhee C.
PMID: 34145449
Clin Infect Dis. 2021 Jun 18; doi: 10.1093/cid/ciab564. Epub 2021 Jun 18.

We assessed SARS-CoV-2 transmission between patients in shared rooms in an academic hospital between September 2020-April 2021. 11,290 patients were admitted to shared rooms, of whom 25 tested positive. Among 31 exposed roommates, 12 (39%) tested positive within 14...

Cite
Karan A, Klompas M, Tucker R, et al. The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab564.
Karan, A., Klompas, M., Tucker, R., Baker, M., Vaidya, V., Rhee, C. (2021). The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab564
Karan, Abraar, et al. "The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab564
Karan A, Klompas M, Tucker R, Baker M, Vaidya V, Rhee C. The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center. Clin Infect Dis. 2021 Jun 18; doi: 10.1093/cid/ciab564. Epub 2021 Jun 18. PMID: 34145449.
Copy Download .nbib Format: NLM
Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection.

Open forum infectious diseases

Willis SJ, Elder H, Cocoros NM, Callahan M, Hsu KK, Klompas M.
PMID: 35024371
Open Forum Infect Dis. 2021 Nov 16;9(1):ofab574. doi: 10.1093/ofid/ofab574. eCollection 2022 Jan.

BACKGROUND: Atrius Health implemented a best practice alert (BPA) to encourage clinicians to provide expedited partner therapy (EPT) in October 2014. We assessed (1) the impact of the BPA on EPT provision and chlamydial reinfection and (2) the impact...

Cite
Willis SJ, Elder H, Cocoros NM, et al. Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection. Open Forum Infect Dis. 2021;9(1):ofab574doi: 10.1093/ofid/ofab574.
Willis, S. J., Elder, H., Cocoros, N. M., Callahan, M., Hsu, K. K., & Klompas, M. (2022). Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection. Open forum infectious diseases, 9(1), ofab574. https://doi.org/10.1093/ofid/ofab574
Willis, Sarah J, et al. "Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection." Open forum infectious diseases vol. 9,1 (2022): ofab574. doi: https://doi.org/10.1093/ofid/ofab574
Willis SJ, Elder H, Cocoros NM, Callahan M, Hsu KK, Klompas M. Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection. Open Forum Infect Dis. 2021 Nov 16;9(1):ofab574. doi: 10.1093/ofid/ofab574. eCollection 2022 Jan. PMID: 35024371; PMCID: PMC8743117.
Copy Download .nbib Format: NLM
Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals.

Critical care explorations

Kuye I, Anand V, Klompas M, Chan C, Kadri SS, Rhee C.
PMID: 33786449
Crit Care Explor. 2021 Mar 16;3(3):e0373. doi: 10.1097/CCE.0000000000000373. eCollection 2021 Mar.

OBJECTIVES: Some patients diagnosed with sepsis have very brief hospitalizations. Understanding the prevalence and clinical characteristics of these patients may provide insight into how sepsis diagnoses are being applied as well as the breadth of illnesses encompassed by current...

Cite
Kuye I, Anand V, Klompas M, et al. Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Crit Care Explor. 2021;3(3):e0373doi: 10.1097/CCE.0000000000000373.
Kuye, I., Anand, V., Klompas, M., Chan, C., Kadri, S. S., & Rhee, C. (2021). Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Critical care explorations, 3(3), e0373. https://doi.org/10.1097/CCE.0000000000000373
Kuye, Ifedayo, et al. "Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals." Critical care explorations vol. 3,3 (2021): e0373. doi: https://doi.org/10.1097/CCE.0000000000000373
Kuye I, Anand V, Klompas M, Chan C, Kadri SS, Rhee C. Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Crit Care Explor. 2021 Mar 16;3(3):e0373. doi: 10.1097/CCE.0000000000000373. eCollection 2021 Mar. PMID: 33786449; PMCID: PMC7994044.
Copy Download .nbib Format: NLM
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.

PLoS medicine

Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van Helmond N, Golafshar MA, Klassen SA, Klompas AM, Sexton MA, Diaz Soto JC, Grossman BJ, Tobian AAR, Goel R, Wiggins CC, Bruno KA, van Buskirk CM, Stubbs JR, Winters JL, Casadevall A, Paneth NS, Shaz BH, Petersen MM, Sachais BS, Buras MR, Wieczorek MA, Russoniello B, Dumont LJ, Baker SE, Vassallo RR, Shepherd JRA, Young PP, Verdun NC, Marks P, Haley NR, Rea RF, Katz L, Herasevich V, Waxman DA, Whelan ER, Bergman A, Clayburn AJ, Grabowski MK, Larson KF, Ripoll JG, Andersen KJ, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Buchholtz ZA, Pletsch MC, Wright K, Greenshields JT, Joyner MJ, Wright RS, Carter RE, Fairweather D.
PMID: 34928960
PLoS Med. 2021 Dec 20;18(12):e1003872. doi: 10.1371/journal.pmed.1003872. eCollection 2021 Dec.

BACKGROUND: The United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. While randomized...

Cite
Senefeld JW, Johnson PW, Kunze KL, et al. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. PLoS Med. 2021;18(12):e1003872doi: 10.1371/journal.pmed.1003872.
Senefeld, J. W., Johnson, P. W., Kunze, K. L., Bloch, E. M., van Helmond, N., Golafshar, M. A., Klassen, S. A., Klompas, A. M., Sexton, M. A., Diaz Soto, J. C., Grossman, B. J., Tobian, A. A. R., Goel, R., Wiggins, C. C., Bruno, K. A., van Buskirk, C. M., Stubbs, J. R., Winters, J. L., Casadevall, A., Paneth, N. S., Shaz, B. H., Petersen, M. M., Sachais, B. S., Buras, M. R., Wieczorek, M. A., Russoniello, B., Dumont, L. J., Baker, S. E., Vassallo, R. R., Shepherd, J. R. A., Young, P. P., Verdun, N. C., Marks, P., Haley, N. R., Rea, R. F., Katz, L., Herasevich, V., Waxman, D. A., Whelan, E. R., Bergman, A., Clayburn, A. J., Grabowski, M. K., Larson, K. F., Ripoll, J. G., Andersen, K. J., Vogt, M. N. P., Dennis, J. J., Regimbal, R. J., Bauer, P. R., Blair, J. E., Buchholtz, Z. A., Pletsch, M. C., Wright, K., Greenshields, J. T., Joyner, M. J., Wright, R. S., Carter, R. E., & Fairweather, D. (2021). Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. PLoS medicine, 18(12), e1003872. https://doi.org/10.1371/journal.pmed.1003872
Senefeld, Jonathon W, et al. "Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study." PLoS medicine vol. 18,12 (2021): e1003872. doi: https://doi.org/10.1371/journal.pmed.1003872
Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van Helmond N, Golafshar MA, Klassen SA, Klompas AM, Sexton MA, Diaz Soto JC, Grossman BJ, Tobian AAR, Goel R, Wiggins CC, Bruno KA, van Buskirk CM, Stubbs JR, Winters JL, Casadevall A, Paneth NS, Shaz BH, Petersen MM, Sachais BS, Buras MR, Wieczorek MA, Russoniello B, Dumont LJ, Baker SE, Vassallo RR, Shepherd JRA, Young PP, Verdun NC, Marks P, Haley NR, Rea RF, Katz L, Herasevich V, Waxman DA, Whelan ER, Bergman A, Clayburn AJ, Grabowski MK, Larson KF, Ripoll JG, Andersen KJ, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Buchholtz ZA, Pletsch MC, Wright K, Greenshields JT, Joyner MJ, Wright RS, Carter RE, Fairweather D. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. PLoS Med. 2021 Dec 20;18(12):e1003872. doi: 10.1371/journal.pmed.1003872. eCollection 2021 Dec. PMID: 34928960; PMCID: PMC8730442.
Copy Download .nbib Format: NLM
Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals.

JAMA network open

Rhee C, Yu T, Wang R, Kadri SS, Fram D, Chen HC, Klompas M.
PMID: 34928358
JAMA Netw Open. 2021 Dec 01;4(12):e2138596. doi: 10.1001/jamanetworkopen.2021.38596.

IMPORTANCE: In October 2015, the Centers for Medicare & Medicaid Services began requiring US hospitals to report adherence to the Severe Sepsis and Septic Shock Early Management Bundle (SEP-1).OBJECTIVE: To evaluate the association of SEP-1 implementation with sepsis treatment...

Cite
Rhee C, Yu T, Wang R, et al. Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals. JAMA Netw Open. 2021;4(12):e2138596doi: 10.1001/jamanetworkopen.2021.38596.
Rhee, C., Yu, T., Wang, R., Kadri, S. S., Fram, D., Chen, H. C., Klompas, M. (2021). Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals. JAMA network open, 4(12), e2138596. https://doi.org/10.1001/jamanetworkopen.2021.38596
Rhee, Chanu, et al. "Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals." JAMA network open vol. 4,12 (2021): e2138596. doi: https://doi.org/10.1001/jamanetworkopen.2021.38596
Rhee C, Yu T, Wang R, Kadri SS, Fram D, Chen HC, Klompas M. Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals. JAMA Netw Open. 2021 Dec 01;4(12):e2138596. doi: 10.1001/jamanetworkopen.2021.38596. PMID: 34928358; PMCID: PMC8689388.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 112 entries